title: Vismodegib-associated hepatotoxicity: a potential side effect detected in postmarketing surveillance.
authors.affiliation: Stony Brook School of Medicine, Department of Dermatology, New York.
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Ventarola
authors.affiliation: Stony Brook School of Medicine, Department of Dermatology, New York. Electronic address: David.silverstein@Stonybrookmedicine.edu.
authors.forename: David I
authors.initials: DI
authors.lastname: Silverstein
mesh_terms: D000328:Adult; D016907:Adverse Drug Reaction Reporting Systems; D000368:Aged; D000369:Aged, 80 and over; D000813:Anilides / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D008297:Male; D008875:Middle Aged; D011725:Pyridines / Q000009:adverse effects*; D013927:Thrombosis / Q000139:chemically induced; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000813:Anilides; D000970:Antineoplastic Agents; C538724:HhAntag691; D011725:Pyridines